All Stories

  1. Enhanced nasopharyngeal infection and shedding associated with an epidemic lineage of emm3 group A Streptococcus
  2. Molecular and Epidemiological Review of Toxigenic Diphtheria Infections in England between 2007 and 2013
  3. External Quality Assessments for Microbiologic Diagnosis of Diphtheria in Europe
  4. Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline
  5. Access to diphtheria antitoxin for therapy and diagnostics
  6. Emergence and molecular characterisation of non-toxigenic tox gene-bearing Corynebacterium diphtheriae biovar mitis in the United Kingdom, 2003–2012
  7. A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development
  8. Increase in scarlet fever notifications in the United Kingdom, 2013/2014
  9. A three year descriptive study of early onset neonatal sepsis in a refugee population on the Thailand Myanmar border
  10. Diphtheria Surveillance
  11. Seroepidemiology of diphtheria and tetanus among children and young adults in Tajikistan: Nationwide population-based survey, 2010
  12. Toxigenic Corynebacterium ulcerans in human and non-toxigenic Corynebacterium diphtheriae in cat
  13. Group B streptococcal epidemiology and vaccine needs in developed countries
  14. Emerging Trends in the Epidemiology of Invasive Group B Streptococcal Disease in England and Wales, 1991-2010
  15. SP14-1 Latest developments in Streptococcus pyogenes: Focus on invasive disease
  16. P194 Molecular anatomy of invasive group A streptococcal (iGAS) isolates in England
  17. P201 Analysing the accessory genome to discover loci responsible for increased morbidity caused by a novel GAS lineage in the UK
  18. P159 Invasive group A streptococcal disease in the UK, 2008–2012 and molecular characterisation of isolates during enhanced surveillance
  19. Molecular Analysis of an Outbreak of Lethal Postpartum Sepsis Caused by Streptococcus pyogenes
  20. The population diversity of Streptococcus zooepidemicus
  21. Diversity of superantigens in Streptococcus equi and zooepidemicus populations
  22. Superantigenic Activity of emm3 Streptococcus pyogenes Is Abrogated by a Conserved, Naturally Occurring smeZ Mutation
  23. Non-culture detection of Streptococcus agalactiae (Lancefield group B Streptococcus) in clinical samples by real-time PCR
  24. Man’s best friend? – First report of prosthetic joint infection with Streptococcus pyogenes from a canine source
  25. Identification of group A streptococcal emm types commonly associated with invasive infections and antimicrobial resistance by the use of multiplex PCR and high-resolution melting analysis
  26. Diphtheria in Europe: current problems and new challenges
  27. Pangenomic Study of Corynebacterium diphtheriae That Provides Insights into the Genomic Diversity of Pathogenic Isolates from Cases of Classical Diphtheria, Endocarditis, and Pneumonia
  28. Group B streptococcal carriage, serotype distribution and antibiotic susceptibilities in pregnant women at the time of delivery in a refugee population on the Thai-Myanmar border
  29. Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project
  30. Diphtheria in the Postepidemic Period, Europe, 2000–2009
  31. Polymorphisms in Regulator of Protease B (RopB) Alter Disease Phenotype and Strain Virulence of Serotype M3 Group A Streptococcus
  32. Evaluation of sclB gene variation in Streptococcus pyogenes (Lancefield group A Streptococcus) and potential for subtyping
  33. Guidelines for prevention and control of group A streptococcal infection in acute healthcare and maternity settings in the UK
  34. International External Quality Assurance for Laboratory Identification and Typing of Streptococcus agalactiae (Group B Streptococci)
  35. Multilocus Sequence Typing Identifies Evidence for Recombination and Two Distinct Lineages of Corynebacterium diphtheriae
  36. Identification of Three Novel Superantigen-Encoding Genes in Streptococcus equi subsp. zooepidemicus, szeF, szeN, and szeP
  37. Diphtheria in the United Kingdom, 1986–2008: the increasing role of Corynebacterium ulcerans
  38. External Quality Assessment for the Determination of Diphtheria Antitoxin in Human Serum
  39. Toxigenic Corynebacterium diphtheriae isolated from a wound in a horse
  40. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996–2006
  41. Invasive group A streptococcal infections in children presenting to a paediatric intensive care unit in the North West of England
  42. A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use
  43. International External Quality Assurance for Laboratory Diagnosis of Diphtheria
  44. Predictors of Death after Severe Streptococcus pyogenes Infection
  45. Group B streptococcal disease in infants: a case control study
  46. Genetic characteristics of pneumococcal disease in elderly patients before introducing the pneumococcal conjugate vaccine
  47. Clinical and Microbiological Characteristics of Severe Streptococcus pyogenes Disease in Europe
  48. Epidemic of severe Streptococcus pyogenes infections in injecting drug users in the UK, 2003–2004
  49. Comparison of Four Molecular Typing Methods for Characterization of Corynebacterium diphtheriae and Determination of Transcontinental Spread of C. diphtheriae Based on BstEII rRNA Gene Profiles
  50. Epidemiology of Severe Streptococcus pyogenes Disease in Europe
  51. SevereStreptococcus pyogenesInfections, United Kingdom, 2003–2004
  52. Biological impact of a prevalent mutation in the major superantigen SMEZ in M3 serotype Streptococcus pyogenes
  53. Circulating serotypes and antimicrobial sensitivity of Streptococcus pyogenes isolates from children in Cyprus
  54. Invasive group A streptococcal infection in injecting drug users and non-drug users in a single UK city
  55. O266 Risk factors for invasive group A streptococcal infections in Europe
  56. International Quality Assurance Study for Characterization of Streptococcus pyogenes
  57. Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998
  58. Corynebacterium spp
  59. β-Haemolytic Streptococci
  60. Outbreak of group A streptococci (Streptococcus pyogenes) in a maternity unit
  61. Group A streptococcal skin infection outbreak in an abattoir: lessons for prevention
  62. Emergence of an Invasive Clone of Nontoxigenic Corynebacterium diphtheriae in the Urban Poor Population of Vancouver, Canada
  63. Screening and Toxigenic Corynebacteria Spread
  64. Characterization of Toxigenic Corynebacterium ulcerans Strains Isolated from Humans and Domestic Cats in the United Kingdom
  65. Invasive group A streptococcal disease: should close contacts routinely receive antibiotic prophylaxis?
  66. A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting
  67. Molecular Characterization of Diphtheria Toxin Repressor (dtxR) Genes Present in Nontoxigenic Corynebacterium diphtheriae Strains Isolated in the United Kingdom
  68. Early-onset neonatal group B streptococcal infection in London: 1990-1999
  69. Characterization of Group B Streptococci Recovered from Infants with Invasive Disease in England and Wales
  70. International nomenclature for Corynebacterium diphtheriae ribotypes
  71. Imported Cutaneous Diphtheria, United Kingdom
  72. Group B streptococcal disease in UK and Irish infants younger than 90 days
  73. A common clone of erythromycin-resistant Streptococcus pneumoniae in Greece and the UK
  74. Increasing incidence of group A streptococcal infections amongst injecting drug users in England and Wales
  75. Predominance of two M-types among erythromycin-resistant group A Streptococci from Greek children
  76. Genotypic and Phenotypic Characteristics of Corynebacterium diphtheriae Strains Isolated from Patients in Belarus during an Epidemic Period
  77. Structural Heterogeneity of the Streptococcal C5a Peptidase Gene in Streptococcus pyogenes
  78. Clonal Relationships Among Isolates of Erythromycin-Resistant Streptococcus pyogenes of Different Geographical Origin
  79. Rifampin Resistance in Streptococcus pyogenes
  80. Immunochromatographic Strip Test for Rapid Detection of Diphtheria Toxin: Description and Multicenter Evaluation in Areas of Low and High Prevalence of Diphtheria
  81. Extension of the Lancefield Classification for Group A Streptococci by Addition of 22 New M Protein Gene Sequence Types from Clinical Isolates: emm103 to emm124
  82. Identification of Isolates of Streptococcus canis Infecting Humans
  83. Unusual Occurrence of M Type 77, Antibiotic-Resistant Group A Streptococci in Southern Sweden
  84. Invasive Pneumococcal Disease in England and Wales: Vaccination Implications
  85. Genetic relatedness of group A streptococci of the newly designated serotype M90 causing a food-borne outbreak and sporadic infections
  86. Effect on Diphtheria Immunity of Combined Tetanus and Diphtheria Booster Vaccination in Adults
  87. Genetic Relationships between Clinical Isolates of Streptococcus pneumoniae, Streptococcus oralis, and Streptococcus mitis: Characterization of “Atypical” Pneumococci and Organisms Allied to S. mitis HarboringS. pneumoniae Virulence Factor-Encoding Genes
  88. Group A streptococci in the 1990s
  89. Molecular Epidemiology of Diphtheria
  90. Current Approaches to the Laboratory Diagnosis of Diphtheria
  91. The European Laboratory Working Group on Diphtheria: A Global Microbiologic Network
  92. Study on the use of an enzyme-linked immunosorbent assay in determining human antibodies to diphtheria toxin as compared with a reference toxin neutralization assay
  93. Outbreak of rare serotype of group A streptococcus pharyngitis in a boarding college
  94. PCR typing of Corynebacterium diphtheriae by random amplification of polymorphic DNA
  95. Extensive genetic diversity among clinical isolates of Streptococcus pyogenes serotype M5
  96. Clonal Spread of Group A Streptococcus with the New Type of Erythromycin Resistance
  97. Pneumococci Causing Invasive Disease in Britain 1982-1990
  98. Pyogenic streptococci of Lancefield groups C and G as pathogens in man
  99. High-Resolution Genotyping of Streptococcus pyogenes
  100. Two Clusters of Invasive Streptococcus pyogenes Infection in England
  101. Invasive Group A Streptococcal Infections
  102. Necrotising Fasciitis Associated with Invasive Group A Streptococcal Infections in England and Wales
  103. Group A Streptococcal Invasive Disease in England and Wales
  104. Virulence regulon polymorphism in group A streptococci revealed by long PCR and implications for epidemiological and evolutionary studies
  105. Pneumococcal meningitis in the North East Thames Region UK: epidemiology and molecular analysis of isolates
  106. Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995
  107. Microbiology and Epidemiology of Diphtheria
  108. Diphtheria in the 1990s: Return of an old adversary
  109. A cluster of cases of streptococcal necrotizing fasciitis in Gloucestershire
  110. Epidemiology and molecular characterisation of toxigenic Corynebacterium diphtheriae var mitis from a case of cutaneous diphtheria in Manchester
  111. An imported fatal case of diphtheria in Italy
  112. Diphtheria immunity in UK blood donors
  113. Distribution of serovariants of group B streptococci in isolates from England and Norway
  114. An outbreak of Group C streptococcal infection in a Maternity Unit
  115. Biochemical differences among human and animal streptococci of Lancefield group C or group G
  116. Polymerase chain reaction for screening clinical isolates of corynebacteria for the production of diphtheria toxin.
  117. The in-vitro susceptibilities of toxigenic strains of Corynebacterium diphtheriae isolated in northwestern Russia and surrounding areas to ten antibiotics
  118. Investigation of milk-borne Streptococcus zooepidemicus infection associated with glomerulonephritis in Australia
  119. Corynebacterium jeikeium
  120. Glycopeptide-resistant Gemella haemolysans from blood
  121. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease
  122. Laboratory diagnosis of strangles and the isolation of atypical Streptococcus equi
  123. Diphtheria and travel
  124. Invasive Disease Caused by Multiple Clones of Corynebacterium diphtheriae
  125. Non-toxigenic Corynebacterium diphtheriae var gravis in England
  126. Type V group B streptococcal septicaemia with bilateral endophthalmitis and septic arthritis
  127. Screening for Corynebacterium diphtheriae.
  128. Screening tests for pathogenic corynebacteria.
  129. Routine screening for Corynebacterium diphtheriae
  130. The presence of M proteins in outbreak strains of Streptococcus equisimilis T-type 204
  131. Outbreaks of human infection caused by pyogenic streptococci of Lancefield groups C and G
  132. An outbreak of puerperal fever caused by group C streptococci
  133. Vancomycin-resistant leuconostocs, lactobacilli and now pediococci
  134. Characterization of Streptococcus zooepidemicus (Lancefield group C) from human and selected animal infections
  135. The preparation of antisera to the T-proteins of Lancefield group C and group G streptococci
  136. The serotyping of hospital strains of streptococci belonging to Lancefield group C and group G
  137. Serological grouping of streptococci by slide agglutination.
  138. The ortho-nitrophenol (ONPG) test and acid from lactose in Gram-negative genera
  139. Diagnosis and Epidemiology of Diphtheria